Articles Tagged with: ans webinar -- ANS / Newswire

About ANS
- ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
About Nuclear
- Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Communities
- Division Spotlight
  Decommissioning & Environmental Sciences
  The mission of the Decommissioning and Environmental Sciences (DES) Division is to promote the development and use of those skills and technologies associated with the use of nuclear energy and the optimal management and stewardship of the environment, sustainable development, decommissioning, remediation, reutilization, and long-term surveillance and maintenance of nuclear-related installations, and sites. The target audience for this effort is the membership of the Division, the Society, and the public at large.
Meetings
- Meeting Spotlight
  2021 Student Conference
  April 8–10, 2021
  Virtual Meeting
Standards
- Standards Program
  The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Publications
- Latest Magazine Issues
  Feb 2021
  Jul 2020
  Latest Journal Issues
  Nuclear Science and Engineering
  March 2021
  Nuclear Technology
  February 2021
  Fusion Science and Technology
  January 2021
Newswire
- - Latest News
- Latest News
  Researchers report fastest purification of astatine-211 needed for targeted cancer therapy
  Astatine-211 recovery from bismuth metal using a chromatography system. Unlike bismuth, astatine-211 forms chemical bonds with ketones.
  In a recent study, Texas A&M University researchers have described a new process to purify astatine-211, a promising radioactive isotope for targeted cancer treatment. Unlike other elaborate purification methods, their technique can extract astatine-211 from bismuth in minutes rather than hours, which can greatly reduce the time between production and delivery to the patient.
  “Astatine-211 is currently under evaluation as a cancer therapeutic in clinical trials. But the problem is that the supply chain for this element is very limited because only a few places worldwide can make it,” said Jonathan Burns, research scientist in the Texas A&M Engineering Experiment Station’s Nuclear Engineering and Science Center. “Texas A&M University is one of a handful of places in the world that can make astatine-211, and we have delineated a rapid astatine-211 separation process that increases the usable quantity of this isotope for research and therapeutic purposes.”
  The researchers added that this separation method will bring Texas A&M one step closer to being able to provide astatine-211 for distribution through the Department of Energy’s Isotope Program’s National Isotope Development Center as part of the University Isotope Network.
  Details on the chemical reaction to purify astatine-211 are in the journal Separation and Purification Technology.
Search

ANS webinar to focus on low-dose radiation risk

January 20, 2021, 12:04PM|ANS Nuclear Cafe

Join ANS on Thursday, January 21, at noon (ET) for a Q&A with an expert panel as they discuss how to communicate about the risk of low-dose radiation. “Talking About Low-dose Radiation Risk” is a free members-only event that serves as a follow-up to the “Risky Business” President’s Session that took place during the ANS Virtual Winter Meeting last November. The session will take a deeper dive into the many questions generated from the thought-provoking discussion.

Tags:

LinkedIn Twitter Facebook